Metabolic Disorders Drugs Market Report

China Metabolic Disorders Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：205
  • REPORT CODE：GMM1828980
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Metabolic Disorders Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • CellCentric

    • Biophytis

    • Exelixis, Inc

    • Eternygen

    • OxThera

    • Anchor Therapeutics

    • Rhythm

    • Zealand Pharma

    • MedGenome

    • Outpost Medicine

    • Zafgen

    • Mitobridge

    • Nimbus Therapeutics

    By Type:

    • Injection

    • Tablet

    By Application:

    • Other

    • Diabetes

    • Disorders of the Thyroid and Pituitary Gland

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Metabolic Disorders Drugs Market Overview 2018-2029

    • 1.1 China Metabolic Disorders Drugs Industry Development Overview

    • 1.2 China Metabolic Disorders Drugs Industry Development History

    • 1.3 China Metabolic Disorders Drugs Industry Market Size (2018-2029)

    • 1.4 China Metabolic Disorders Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Metabolic Disorders Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

      • 1.4.2 China Metabolic Disorders Drugs Production Volume, Production Value and Growth Rate of Tablet (2018-2029)

    • 1.5 China Metabolic Disorders Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.3 China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2018-2029)

    • 1.6 China Metabolic Disorders Drugs Market Analysis by Region

      • 1.6.1 North China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Metabolic Disorders Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Metabolic Disorders Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Metabolic Disorders Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Metabolic Disorders Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Metabolic Disorders Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Metabolic Disorders Drugs Industry Development

    Chapter 3 Metabolic Disorders DrugsIndustry Chain Analysis

    • 3.1 Metabolic Disorders Drugs Industry Chain

    • 3.2 Metabolic Disorders Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Metabolic Disorders Drugs Market

    • 3.3 Metabolic Disorders Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Metabolic Disorders Drugs Market

    Chapter 4 China Metabolic Disorders Drugs Market, by Type

    • 4.1 China Metabolic Disorders Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Metabolic Disorders Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Metabolic Disorders Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Metabolic Disorders Drugs Production Volume and Growth Rate of Injection

      • 4.5.2 China Metabolic Disorders Drugs Production Volume and Growth Rate of Tablet

    Chapter 5 China Metabolic Disorders Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Metabolic Disorders Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Metabolic Disorders Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Metabolic Disorders Drugs Market Size and Growth Rate of Other

      • 5.5.2 China Metabolic Disorders Drugs Market Size and Growth Rate of Diabetes

      • 5.5.3 China Metabolic Disorders Drugs Market Size and Growth Rate of Disorders of the Thyroid and Pituitary Gland

    Chapter 6 China Metabolic Disorders Drugs Market, by Region

    • 6.1 China Metabolic Disorders Drugs Production Volume and Production Value, by Region

    • 6.2 China Metabolic Disorders Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Metabolic Disorders Drugs Market Analysis

    • 7.1 North China Metabolic Disorders Drugs Market, by Type

    • 7.2 North China Metabolic Disorders Drugs Market, by Application

    Chapter 8 Central China Metabolic Disorders Drugs Market Analysis

    • 8.1 Central China Metabolic Disorders Drugs Market, by Type

    • 8.2 Central China Metabolic Disorders Drugs Market, by Application

    Chapter 9 South China Metabolic Disorders Drugs Market Analysis

    • 9.1 South China Metabolic Disorders Drugs Market, by Type

    • 9.2 South China Metabolic Disorders Drugs Market, by Application

    Chapter 10 East China Metabolic Disorders Drugs Market Analysis

    • 10.1 East China Metabolic Disorders Drugs Market, by Type

    • 10.2 East China Metabolic Disorders Drugs Market, by Application

    Chapter 11 Northeast China Metabolic Disorders Drugs Market Analysis

    • 11.1 Northeast China Metabolic Disorders Drugs Market, by Type

    • 11.2 Northeast China Metabolic Disorders Drugs Market, by Application

    Chapter 12 Southwest China Metabolic Disorders Drugs Market Analysis

    • 12.1 Southwest China Metabolic Disorders Drugs Market, by Type

    • 12.2 Southwest China Metabolic Disorders Drugs Market, by Application

    Chapter 13 Northwest China Metabolic Disorders Drugs Market Analysis

    • 13.1 Northwest China Metabolic Disorders Drugs Market, by Type

    • 13.2 Northwest China Metabolic Disorders Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 CellCentric

        • 14.1.1 CellCentric Company Profile

        • 14.1.2 CellCentric Metabolic Disorders Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Biophytis

        • 14.2.1 Biophytis Company Profile

        • 14.2.2 Biophytis Metabolic Disorders Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Exelixis, Inc

        • 14.3.1 Exelixis, Inc Company Profile

        • 14.3.2 Exelixis, Inc Metabolic Disorders Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eternygen

        • 14.4.1 Eternygen Company Profile

        • 14.4.2 Eternygen Metabolic Disorders Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 OxThera

        • 14.5.1 OxThera Company Profile

        • 14.5.2 OxThera Metabolic Disorders Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Anchor Therapeutics

        • 14.6.1 Anchor Therapeutics Company Profile

        • 14.6.2 Anchor Therapeutics Metabolic Disorders Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Rhythm

        • 14.7.1 Rhythm Company Profile

        • 14.7.2 Rhythm Metabolic Disorders Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Zealand Pharma

        • 14.8.1 Zealand Pharma Company Profile

        • 14.8.2 Zealand Pharma Metabolic Disorders Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 MedGenome

        • 14.9.1 MedGenome Company Profile

        • 14.9.2 MedGenome Metabolic Disorders Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Outpost Medicine

        • 14.10.1 Outpost Medicine Company Profile

        • 14.10.2 Outpost Medicine Metabolic Disorders Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Zafgen

        • 14.11.1 Zafgen Company Profile

        • 14.11.2 Zafgen Metabolic Disorders Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Mitobridge

        • 14.12.1 Mitobridge Company Profile

        • 14.12.2 Mitobridge Metabolic Disorders Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Nimbus Therapeutics

        • 14.13.1 Nimbus Therapeutics Company Profile

        • 14.13.2 Nimbus Therapeutics Metabolic Disorders Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Metabolic Disorders Drugs Industry Research Conclusions

    • 15.2 Metabolic Disorders Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Metabolic Disorders Drugs Industry Market Size (2018-2029)

    • Figure China Metabolic Disorders Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Metabolic Disorders Drugs Production Volume, Production Value and Growth Rate of Tablet (2018-2029)

    • Figure China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Metabolic Disorders Drugs Sales Volume, Sales Value and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2018-2029)

    • Figure North China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Metabolic Disorders Drugs Market Size and Growth Rate from 2018-2029

    • Figure Metabolic Disorders Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Metabolic Disorders Drugs Market Share by Type in 2018

    • Figure China Metabolic Disorders Drugs Market Share by Type in 2023

    • Figure China Metabolic Disorders Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Metabolic Disorders Drugs Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Metabolic Disorders Drugs Production Volume and Growth Rate of Tablet (2018-2023)

    • Figure China Metabolic Disorders Drugs Market Share by Application in 2018

    • Figure China Metabolic Disorders Drugs Market Share by Application in 2023

    • Figure China Metabolic Disorders Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Metabolic Disorders Drugs Market Size and Growth Rate of Other (2018-2023)

    • Figure China Metabolic Disorders Drugs Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Metabolic Disorders Drugs Market Size and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2018-2023)

    • Table China Metabolic Disorders Drugs Production Volume by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Production Volume Share by Region (2018-2023)

    • Figure China Metabolic Disorders Drugs Production Volume Share by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Production Value by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Production Value Share by Region (2018-2023)

    • Figure China Metabolic Disorders Drugs Production Value Share by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Sales Volume by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Metabolic Disorders Drugs Sales Volume Share by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Sales Value by Region (2018-2023)

    • Table China Metabolic Disorders Drugs Sales Value Share by Region (2018-2023)

    • Figure China Metabolic Disorders Drugs Sales Value Share by Region (2018-2023)

    • Table North China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table North China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table North China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table North China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table Central China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table Central China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table South China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table South China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table South China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table East China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table East China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table East China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Metabolic Disorders Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Metabolic Disorders Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Metabolic Disorders Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Metabolic Disorders Drugs Sales Volume Share by Application (2018-2023)

    • Table CellCentric Company Profile

    • Table CellCentric Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Biophytis Company Profile

    • Table Biophytis Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Exelixis, Inc Company Profile

    • Table Exelixis, Inc Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Eternygen Company Profile

    • Table Eternygen Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table OxThera Company Profile

    • Table OxThera Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Anchor Therapeutics Company Profile

    • Table Anchor Therapeutics Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Rhythm Company Profile

    • Table Rhythm Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Zealand Pharma Company Profile

    • Table Zealand Pharma Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table MedGenome Company Profile

    • Table MedGenome Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Outpost Medicine Company Profile

    • Table Outpost Medicine Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Zafgen Company Profile

    • Table Zafgen Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Mitobridge Company Profile

    • Table Mitobridge Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)

    • Table Nimbus Therapeutics Company Profile

    • Table Nimbus Therapeutics Metabolic Disorders Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US